This is the patient advocacy group in Australia for neuroendocrine neoplasms
You can join support groups, contact a NET nurse and access many patient information pages here, including management of common symptoms like diarrhoea: https://neuroendocrine.org.au/fact-sheets/managing-diarrhoea-with-a-neuroendocrine-tumour/
Octreotate, the metabolically active element of Lutate, is a somatostatin analogue that is rapidly bound to these receptors, which is labeled with 177- Lutetium is a short-range, beta-radiation emitter, which delivers a therapeutic dose of radiation to the target tumours. The full name is 177Lu-DOTA-Octreotate.
Capecitabine and temozolomide chemotherapy:
Capecitabine and temozolomide chemotherapy:
Sandostatin injections:
Everolimus tablets:
